SCHEMBL15566856

SCHEMBL15566856

CC(C)CC(=O)N1CCCC(C(=O)O)C1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.50
▸ SMN1; SMN2 Q16637 3/20 0.50
▸ HPGD P15428 2/20 0.50
▸ NPC1 O15118 1/20 0.50
▸ TSHR P16473 1/20 0.50
▸ RAB9A P51151 1/20 0.50
▸ XPNPEP2 O43895 1/20 0.46
▸ ACE P12821 1/20 0.46
▸ CREBBP Q92793 1/20 0.44
▸ ITGB3 P05106 3/20 0.44
▸ ITGA2B P08514 3/20 0.44
▸ F2R P25116 2/20 0.44
▸ KDM4E B2RXH2 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ MAPK1 P28482 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15607433 1.00 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2HPGDNPC1TSHR
SCHEMBL26213401 0.90 PTPN1 (0.49) ALDH1A1SMN1; SMN2HPGDNPC1TSHR
SCHEMBL26724931 0.87 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2HPGDNPC1TSHR
SCHEMBL26213281 0.83 ALDH1A1 (0.53) ALDH1A1SMN1; SMN2HPGDNPC1TSHR
SCHEMBL25854792 0.83 SMN1; SMN2 (0.50) ALDH1A1SMN1; SMN2XPNPEP2ACEKDM4E
SCHEMBL12182476 0.81 MEN1 (0.58) ALDH1A1SMN1; SMN2HPGDNPC1TSHR
SCHEMBL15607287 0.81 ALDH1A1 (0.70) ALDH1A1SMN1; SMN2HPGDNPC1TSHR
SCHEMBL22106447 0.81 ALDH1A1 (0.70) ALDH1A1SMN1; SMN2HPGDNPC1TSHR
SCHEMBL18731164 0.80 ALDH1A1 (0.65) ALDH1A1SMN1; SMN2HPGDNPC1RAB9A
SCHEMBL19104798 0.80 SMN1; SMN2 (0.44) ALDH1A1SMN1; SMN2HPGDNPC1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11873291-B2 Quinoline cGAS antagonist compounds IMMUNESENSOR THERAPEUTICS, INC. (US) 2024-01-16 — — US disclosed
US-20230357158-A1 QUINOLINE cGAS ANTAGONIST COMPOUNDS THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2023-11-09 — — US disclosed
WO-2023168367-A1 QUINOLINE cGAS ANTAGONIST COMPOUNDS IMMUNESENSOR THERAPEUTICS, INC. (US) 2023-09-07 — — WO disclosed
EP-3593648-B1 SWEET FLAVOR MODIFIER FIRMENICH INCORPORATED (US) 2021-07-14 — — EP disclosed
EP-2880031-B1 SWEET FLAVOR MODIFIER FIRMENICH INCORPORATED (US) 2020-06-17 — — EP disclosed
CN-104603132-B Sweet taste modifier 弗门尼舍公司 2020-02-21 — — CN disclosed
US-9745293-B2 Sweet flavor modifier SENOMYX, INC. (US) 2017-08-29 — — US disclosed
US-20170183336-A1 SWEET FLAVOR MODIFIER SENOMYX, INC. 2017-06-29 — — US disclosed
US-9687015-B2 Sweet flavor modifier SENOMYX, INC. (US) 2017-06-27 — — US disclosed
US-20160331013-A1 SWEET FLAVOR MODIFIER SENOMYX, INC. 2016-11-17 — — US disclosed
US-9420814-B2 Sweet flavor modifier SENOMYX, INC. (US) 2016-08-23 — — US disclosed
US-20150374020-A1 SWEET FLAVOR MODIFIER SENOMYX, INC. 2015-12-31 — — US disclosed
US-9138013-B2 Sweet flavor modifier SENOMYX, INC. (US) 2015-09-22 — — US disclosed
EP-2880031-A1 SWEET FLAVOR MODIFIER Senomyx, Inc. (US) 2015-06-10 — — EP disclosed
US-20150031684-A1 SWEET FLAVOR MODIFIER SENOMYX, INC 2015-01-29 — — US disclosed
US-8877922-B2 Sweet flavor modifier SENOMYX, INC. (US) 2014-11-04 — — US disclosed
WO-2014025706-A1 SWEET FLAVOR MODIFIER SENOMYX, INC. (US) 2014-02-13 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150374020-A1 SWEET FLAVOR MODIFIER TAS2R5, TAS2R10, TAS2R50 ALDH1A1 613/4885SMN1; SMN2 3389/4885HPGD 2426/4885
US-20150031684-A1 SWEET FLAVOR MODIFIER TAS2R5, TAS2R10, TAS2R50 ALDH1A1 613/4885SMN1; SMN2 3389/4885HPGD 2426/4885
US-11873291-B2 Quinoline cGAS antagonist compounds CGAS, GLS2, GLS ALDH1A1 4236/4885SMN1; SMN2 2633/4885HPGD 905/4885
US-20230357158-A1 QUINOLINE cGAS ANTAGONIST COMPOUNDS CGAS, GLS2, GLS ALDH1A1 4236/4885SMN1; SMN2 2633/4885HPGD 905/4885
US-20170183336-A1 SWEET FLAVOR MODIFIER TAS2R5, TAS2R10, TAS2R50 ALDH1A1 445/4885SMN1; SMN2 3349/4885HPGD 2313/4885
US-20160331013-A1 SWEET FLAVOR MODIFIER TAS2R5, TAS2R10, TAS2R50 ALDH1A1 445/4885SMN1; SMN2 3349/4885HPGD 2313/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback